CMVM approves the release of Bolsa Saúde

AAs a result, the CMVM indicated that "following the application lodged on May 3, 2018 by Luz Saúde at the meeting of its board of directors held on November 27, 2018, it was decided to to grant a claim for loss of status ". present. "

The regulator then specified that "in order to comply with the provisions of paragraph 3 of Article 27 of the Securities Code, Fidelidade – Companhia de Seguros SA is committed to acquire the shares held by shareholders present or represented, or having voted in favor of the said resolution, having promised for this purpose their respective payment to Caixa – Banco de Investimento, SA ".

The value of this counterparty will be available for three months, at a unit price of 5.71 euros per share, corresponding to "the commitment made by Fidelidade Companhia de Seguros SA in the proposal approved by the extraordinary general meeting of the April 13, 2018 and this also corresponds to the higher price paid during the six months preceding the announcement of the convening to the general meeting. "

This amount was obtained "in connection with the conclusion of a contract for the purchase and sale of 46,815,704 shares representing the capital of Luz Saúde between Fidelidade and Fosun Internacional Limited", according to the same release. .

The loss of the public company status implies, explains the CMVM, "the immediate exclusion from trading on a regulated market of the company's shares and the securities which give right to their subscription or acquisition, their prohibition of readmission for a period of one year ".

In March, Fidelidade, the largest shareholder of Luz Saúde, discussed the "concentration of share capital" of shareholders of Fosun, with 98.788% of the capital and voting rights, and estimated that "it is not necessary to take into account the is not justified to maintain the status ". Luz Saúde, taking into account the costs and formalities inherent in this status. "

Thus, he proposed "to proceed to the determination of the loss of quality of a public company, with the consequence of the immediate exclusion of the trading on the regulated market of Luz Saúde shares".